NCT00187057View on ClinicalTrials.gov

Study for Treatment of Cancer in Children With Ataxia-telangiectasia

NACompletedINTERVENTIONAL
Enrollment

6

Participants

Timeline

Start Date

September 30, 2002

Primary Completion Date

August 31, 2006

Study Completion Date

June 30, 2013

Conditions
Ataxia-Telangiectasia
Interventions
DRUG

vinblastine, vincristine, prednisone, daunorubicin

See Detailed Description section for details of treatment interventions.

DRUG

doxorubicin, methotrexate, cyclophosphamide, L-asparaginase

See Detailed Description section for details of treatment interventions.

DRUG

etoposide, cytarabine, mercaptopurine

See Detailed Description section for details of treatment interventions.

DRUG

dexamethasone, procarbazine

See Detailed Description section for details of treatment interventions.

PROCEDURE

chemotherapy, intrathecal chemotherapy, steroid therapy

See Detailed Description section for details of treatment interventions.

Trial Locations (1)

38105

St. Jude Children's Research Hospital, Memphis

All Listed Sponsors
collaborator

Children's Hospital of Philadelphia

OTHER

collaborator

National Cancer Institute (NCI)

NIH

lead

St. Jude Children's Research Hospital

OTHER

NCT00187057 - Study for Treatment of Cancer in Children With Ataxia-telangiectasia | Biotech Hunter | Biotech Hunter